Pharmacy Health PLUS Immune Force — recall
Health products · Australia · 2026-10-15
Pharmacy Health PLUS Immune Force, allergy risk
→ See all Australian Pharmaceutical Industries recalls
| Country | Australia |
|---|---|
| Category | Health products |
| Published | 2026-10-15 |
| Company | Australian Pharmaceutical Industries Pty Ltd |
| Batch / expiry | All batches within expiry |
| Product type | Medicine |
| Registration no. (ARTG) | 453125 |
| Recall level | Consumer |
| Hazard class | Class I |
| Reason | Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no lon… |
| Recall type | Recall |
| Remedy | Distributors/retailers • Inspect stock immediately and quarantine all stock of Pharmacy Health PLUS Immune Force on hand to prevent further use or distribution. • Return affected stock on hand with the completed response form to the respective Distribution Centre. • Following receipt of stock, API will contact customers to arrange a credit for the returned stock. Consumers • Consumers are advised that if they have the above product, to not use it. • Consumers can return the product to the place of purchase for a refund. • If someone is suspected of having anaphylaxis, call for emergency med… |
| Affected area | Australia |
| Recall number | RC-2026-RN-00802-1 |
| Official notice | View source ↗ |
Get alerted when Australian Pharmaceutical Industries has another recall
Free: we'll email you when Australian Pharmaceutical Industries appears in a new official recall across 11 markets, including the US, EU and Japan.
Watch Australian Pharmaceutical Industries recalls — free →What this means for sellers
| Likely platform / channel actions | Retailers/importers typically pull and return stock; similar products may face tighter border checks. |
|---|---|
| Self-check for comparable products | Check your comparable products' design, materials and QC records against the defect described here. |
| Rules & standards likely involved | the destination market's product-safety rules and mandatory standards |
🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →
General guidance only — not compliance or legal advice; the official notice and applicable law prevail.
Stay ahead of recalls like this
Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.
By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).
Related health products recalls
- Immune Forte 1-A-Day 90 & 100 Caps and Immune Defence 120 TabsAustralia · 2026-10-15
- Calcium Breakthrough CapsulesAustralia · 2026-10-15
- Fusion Health VIRAFORCE 30 and 60 CapsulesAustralia · 2026-10-14
- Immunity Boost Forte (30s & 60s)Australia · 2026-10-14
- My Immune Cold + FluAustralia · 2026-11-18
- Xiao Yan Li Dan Tablet, High Strength Chuan Xin Lian Antiphlogistic Tablet and Lian Zhi X…Australia · 2026-11-18
- Caruso’s Immune Aid 60 film coated tabletsAustralia · 2026-11-16